Vineti, Inc.

Vineti, Inc.

Vineti, Inc.

Overview
Date Founded

2016

Headquarters

633 Howard Street SAN FRANCISCO CA 94105

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Hospitals & Patient Services
Industrial Machinery & Manufacturing
Internet Software & Services
Computer Software
Holding Companies

Company Description

Vineti, Inc. develops software for scaling and digital solutions for cell and gene therapies. The firm focuses on enabling life changing autologous therapies, supporting standards, and developing infrastructure that will expand patient access through expedited discovery, delivery and regulation in the field. The company was founded by Heidi Hagen, Malek Faham, Amy DuRoss and Razmik Abnous and is headquartered in Menlo Park, CA.

Executives & Employees

Co-Founder & Chief Executive Officer

Chief Operating Officer & Chief Financial Officer

Chief Product Officer

Chief Strategy Officer

Senior Vice President Finance & Operations

Vice President, Software Products

Board of Directors

Head of Precision Diagnostics at GE Healthcare, Inc.

Managing Partner at Section 32 LLC

Partner at Threshold Ventures, Inc.

Co-Founder & Chief Executive Officer at Vineti, Inc.

General Partner at Canaan Management, Inc.

General Manager at GE Ventures LLC

Former Vice President-Biotechnologies at GE Healthcare Ltd.

Paths to Vineti, Inc.
Potential Connections via
Relationship Science
You
Vineti, Inc.
Recent Transactions
Details Hidden

Vineti, Inc. raised money in a private placement transaction

Details Hidden

Vineti, Inc. raised money in a private placement transaction

Details Hidden

Vineti, Inc. raised money in a private placement transaction

Investors
Details Hidden

Section 32 invests in companies located in the US. The firm focuses on companies operating in the fields of frontiers of technology,healthcare and the life sciences software, cybersecurity, machine learning, and artificial intelligence. The firm provides financing for early stage capital requirements.

Details Hidden

Casdin Capital invests in early stage companies located in the US. The firm targets companies operating in the fields of life sciences and healthcare industry.

Details Hidden

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vineti, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vineti, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vineti, Inc..